Refractory coeliac disease: remission with infliximab and immunomodulators.

Turner SM; Moorghen M; Probert CS

首页> 外文期刊>European journal of gastroenterology and hepatology >Refractory coeliac disease: remission with infliximab and immunomodulators.

【24h】

Refractory coeliac disease: remission with infliximab and immunomodulators.

机译：难治性乳糜泻：英夫利昔单抗和免疫调节剂缓解。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Coeliac disease is a T-cell-mediated enteropathy induced by gluten. A minority of patients who fail to respond to a gluten-free diet may require intervention with immunomodulating drugs. We report a case of refractory coeliac disease where remission was induced by the anti-tumour necrosis factor-alpha antibody infliximab and was maintained with prednisolone and azathioprine.

机译：腹腔疾病是由面筋引起的T细胞介导的肠病。少数对无麸质饮食无反应的患者可能需要用免疫调节药物进行干预。我们报告一例难治性乳糜泻，其中抗肿瘤坏死因子-α抗体英夫利昔单抗诱导缓解，并用泼尼松龙和硫唑嘌呤维持。

著录项

来源
《European journal of gastroenterology and hepatology》 |2005年第6期|共3页
作者
Turner SM; Moorghen M; Probert CS;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
Antibodies; Monoclonal; Celiac Disease; Gastrointestinal Agents; Tumor Necrosis Factor-alpha; 抗体; 单克隆; 乳糜泻; 胃肠病用药;

机译：Antibodies;Monoclonal;Celiac Disease;Gastrointestinal Agents;Tumor Necrosis Factor-alpha;抗体;单克隆;乳糜泻;胃肠病用药;

相似文献

外文文献
中文文献
专利

1. Refractory coeliac disease: remission with infliximab and immunomodulators. [J] . Turner SM, Moorghen M, Probert CS European journal of gastroenterology and hepatology . 2005,第6期

机译：难治性乳糜泻：英夫利昔单抗和免疫调节剂缓解。
2. Infliximab in refractory coeliac disease. [J] . Chaudhary R, Ghosh S European journal of gastroenterology and hepatology . 2005,第6期

机译：英夫利昔单抗治疗难治性腹腔疾病。
3. Efficacy of Infliximab for Early Remission Induction in Refractory Uveoretinitis Associated with Behcet Disease: A 2-year Follow-up Study [J] . Keino Hiroshi, Okada Annabelle A., Watanabe Takayo, Ocular immunology and inflammation . 2017,第1期

机译：英夫利昔单抗对难治性uvenoretinitinith中早期缓解诱导的疗效：2年的后续研究
4. REFRACTORY COELIAC DISEASE: AN OPPORTUNITY TO PREVENT A T-CELL LYMPHOMA [C] . W. H. M. Verbeek, M. W. J. Schreurs, A. Al-Toma, International Conference of Gluten-Free Cereal Products and Beverages . 2009

机译：难治性乳糜泻：防止T细胞淋巴瘤的机会
5. A Cost-utility Analysis of Biosimilar Infliximab Compared to Reference Infliximab in Adult Switch Patients with Crohn's Disease: A Canadian Analysis [D] . Hughes, Avery. 2018

机译：生物纤维生素infiximab的成本实用性分析与成人交换患者参考incriximab患者克罗恩病患者：加拿大分析
6. Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient [O] . Nidhi Rawal, William Twaddell, Alessio Fasano, 2015

机译：英夫利昔单抗治疗小儿顽固性乳糜泻
7. Editorial: risk factors for persistent villus atrophy in coeliac disease - is it time to reconsider definitions for refractory coeliac disease? [O] . M. R. H. Braude, E. D. Newnham 2017

机译：社论：腹腔疾病持久性绒毛萎缩的危险因素 - 是时候重新考虑难治性乳糜泻的定义时间？

Refractory coeliac disease: remission with infliximab and immunomodulators.

摘要

著录项

相似文献

相关主题

期刊订阅